USP22 and gastric cancer: Additionally, overexpression of miR-200b-5p, a regulator of USP22, suppresses gastric cancer cell proliferation and migration by targeting the NF−κB pathway, highlighting its potential as a new therapeutic target in gastric cancer (274).